Photos show the rocket and spacecraft that NASA will use to launch astronauts toward the moon for the first time in more than 50 years.

A flu strain that emerged over the summer is causing outbreaks in other countries. The CDC hasn't provided any insights on what's happening in the U.S. in weeks.

(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ​signals in the "reward center" of the brain. These are the first direct measurements of brain activity ‌in a person receiving tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, shedding light on the treatment's impact on so-called ‌food noise.